Bioinformatics: Technologies and Global Markets

Publication Month: May 2021 | No. of Pages: 345 Published By: BCC RESEARCH
Single User License: US $ 5500
Corporate User License: US $ 9504

Report Scope:

The scope of the study encompasses the global bioinformatics market based on geography, category and application. It provides a detailed analysis of recent advances in omic technologies and examines their impact on the bioinformatics market. It discusses the ways in which bioinformatics has been utilized by the pharma and biotech industries to streamline the research and development (R&D) process and improve efficiencies. It provides a detailed analysis of the leading countries, companies and technologies that will drive the field forward.

By geography, the market has been segmented into the North America, Europe, Asia-Pacific, South America, and Middle East and Africa regions. Detailed analysis of major countries such as the U.S., Germany, the U.K., Italy, France, Spain, Japan, China, India, Brazil, Mexico, GCC countries and South Africa will be covered in the regional segment. For market estimates, data will be provided for 2019 as the base year, with estimates for 2020 and forecast value for 2025.

Report Includes:

- 51 data tables and 84 additional tables
- An overview of the global markets and technologies for bioinformatics
- Analyses of global market trends, with data from 2018, 2019, 2020 and projections of compound annual growth rates (CAGRs) through 2025
- Evaluation of market size and forecast, and market share analysis of bioinformatics based on categories, applications, sequence services and platforms, region, and end-users
- Highlights of technological advancements and innovations in bioinformatics solutions for drug discovery and insights into investments and funding for the development of bioinformatics solutions
- Assessment of challenges and opportunities in the bioinformatics market and description of high-throughput technologies such as next-generation sequencing (NGS), big data analysis and cloud-based solutions
- Coverage of new discoveries in biological sciences; details of antibody-based drug discovery and development; prevalence of chronic diseases and impact analysis of COVID-19 on bioinformatics company
- Identification of innovative companies and technologies that are moving forward in search for elusive pieces of information that will improve diagnoses and treatments of diseases with precision medicines
- Market share analysis of the key companies of the industry and coverage of events like mergers & acquisitions, joint ventures, collaborations or partnerships, and other key market strategies
- Comprehensive company profiles of major players of the industry, including Illumina Inc., Genedata AG, Qlucore AB, GNS Healthcare Inc., Smartgene Services SARL and Real Time Genomics Inc.

Table of Contents
Chapter 1 Introduction
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Information Sources
Methodology
Geographic Breakdown
Analyst's Credentials
BCC Custom Research
Related BCC Research Reports
Chapter 2 Summary and Highlights
Chapter 3 Market and Technology Background
Introduction
Biological Data Sources
Bioinformatics in Systems Biology
Bioinformatics in Precision Medicine
Bioinformatics in Drug Development
Cheminformatics
Next-Generation Sequencing
Bioinformatics in Metagenomics
Bioinformatics in Database Management Systems
Market Trends
Precision Medicine and Biomarker Identification
Cloud-Based Solutions
Shift Toward Value-Based Care
Market Challenges
Data Integration
Data Reliability and Standardization
End-to-End Workflows
Market Trends in Bioinformatics Tools and Software
Purchasing Factors Analysis
Analyzing Experimental Data
Chapter 4 Research Funding for Bioinformatics
Research Grants
Public Funding
Private Funding
Chapter 5 Market Dynamics
Market Drivers
New Discoveries in Biological Sciences
Increasing Use of Bioinformatics Analytical Software
New Antibody Technologies and Antibody Types
Antibody-Based Drug Discovery and Development
Developed and Increasing Research Areas
Increased Government Funding in Emerging Markets
Need for Further Human Genomic and Proteomic Research
New Application-Focused Technology Platforms
Market Restraints
Challenging Issues of Modeling Systems
Ethical Concerns of Bioinformatics and Computational Genomics
Market Opportunities
Market Expansion into Emerging Countries
Development of Novel Bioinformatics and Drugs
Chapter 6 Market Breakdown by Application
Information Overload
Data Volume
Data Variety
Data Velocity
Data Veracity
Software Scalability and Validity
Global Market for Bioinformatics by Application
Genomics
Proteomics
Transcriptomics
Metabolomics
Cheminformatics
Pharmacogenomics
Metagenomics
Other Applications
Chapter 7 Market for Sequencing Services and Platforms
Global Market for Sequencing Services and Platforms
Sequencing Services
Sequencing Platforms
Chapter 8 Market Breakdown by Solution
Global Market for Bioinformatics by Solution
Bioinformatic Tools and Database Services
Database Management Services
IT Hardware and Infrastructure
Chapter 9 Market Breakdown by End User
Global Market for Bioinformatics by End User
Research
Clinical and Medical
Other End Users
Chapter 10 Market Breakdown by Region
Global Market for Bioinformatics by Region
North America
Europe
Asia-Pacific
Rest of the World
Chapter 11 Impact of COVID-19 on the Pharmaceutical/Biotechnology Industry
Short-Term Impact
Change in Demand
Shift of Communication and Promotions to Remote Interactions
Research and Development Changes
Long-Term Impact
Delayed Approvals for Non-COVID-Related Pharmaceutical/Biotech Products
Self-Sufficiency in Pharma/Biotech Industry
Pharmaceutical Industry Growth Slow-Down
Changes in Consumption Trends in Health-Related Products
Chapter 12 Bioinformatics Applications in Pharmaceutical R&D
Introduction
Drug Discovery and Development Process
Target Identification
Target Validation
Lead Identification
Lead Optimization
Clinical Research: Drug Development
Preclinical Experiments
Investigational New Drug Applications
Clinical Trials
New Drug Application
NDA Approval
Post-Launch Ongoing Studies and Phase IV Clinical Trials
Electronic Health Records
Mobile Health Technologies
Recent Pharmaceutical and Bioinformatics Alliances and Partnerships
Conclusions
Chapter 13 Competitive Landscape
Global Company Market Ranking Analysis
Chapter 14 Company Profiles
3RD MILLENNIUM INC.
AGILENT TECHNOLOGIES INC.
BIOMATTERS LTD. GENEIOUS
BIO-RAD (ABD SEROTEC)
BIO-TECHNE
COMPUGEN LTD.
DASSAULT SYSTEMES BIOVIA
DNASTAR, INC.
GENEDATA AG
GENEVA BIOFORMATICS (GENEBIO) SA
GENOMATIX SOFTWARE GMBH
GNS HEALTHCARE INC.
GVK BIOSCIENCES PVT. LTD.
ILLUMINA INC.
INTE:LIGAND SOFTWARE ENTWICKLUNGS UND CONSULTING GMBH
MACVECTOR INC.
MOLECULAR CONNECTIONS PVT. LTD.
MOLECULAR NETWORKS GMBH
NONLINEAR DYNAMICS LTD.
OCIMUM BIOSOLUTIONS LTD.
PERKINELMER INFORMATICS INC.
PERSONALIS INC.
QLUCORE AB
REAL TIME GENOMICS INC.
SMARTGENE SERVICES SARL
SYNGENE INTERNATIONAL
THERMO FISHER SCIENTIFIC INC.
Chapter 15 Appendix: Acronyms

Tables and Figures

List of Tables
Summary Table : Global Market for Bioinformatics, by Application, Through 2025
Table 1 : Recommendations for NGS Bioinformatics Tools
Table 2 : Bioinformatics Tools Used for Metagenomics Analysis
Table 3 : DBMS Platforms in Bioinformatics
Table 4 : Growth in Selected EMBL-EBI Resources, 2015 and 2016
Table 5 : Public Funding Programs, 2012-2018
Table 6 : Global Market for Bioinformatics, by Application, Through 2025
Table 7 : Cloud-Based Bioinformatics Tools
Table 8 : Global Market for Bioinformatics in Genomics Applications, by Region, Through 2025
Table 9 : Global Market for Bioinformatics in Proteomics Applications, by Region, Through 2025
Table 10 : Global Market for Bioinformatics in Transcriptomics Applications, by Region, Through 2025
Table 11 : Commercially Available Metabolomics Software
Table 12 : Open Access Tools for Complex Liquid Chromatography-Mass Spectrometry Data Analysis
Table 13 : Global Market for Bioinformatics in Metabolomics Applications, by Region, Through 2025
Table 14 : Cheminformatics Software Solutions for Drug R&D
Table 15 : Global Market for Bioinformatics in Cheminformatics Applications, by Region, Through 2025
Table 16 : Pharmacogenomic Biomarkers in Drug Labeling
Table 17 : Recent Research on Biomarkers
Table 18 : Global Market for Bioinformatics in Pharmacogenomics Applications, by Region, Through 2025
Table 19 : Bioinformatic Tools and Databases Used in Pharmacogenomics
Table 20 : Bioinformatic Tools for Pharmacogenomic Studies
Table 21 : Global Market for Bioinformatics in Metagenomics Applications, by Region, Through 2025
Table 22 : Toxicogenomic Studies Planned or Ongoing, 2016
Table 23 : Global Market for Bioinformatics in Other Applications, by Region, Through 2025
Table 24 : Global Market for Sequencing Services and Platforms, Through 2025
Table 25 : Global Market for Sequencing Services, by Region, Through 2025
Table 26 : Sequence Analysis Software
Table 27 : Global Market for Sequencing Platforms, by Region, Through 2025
Table 28 : Sequence Alignment Platforms
Table 29 : Global Market for Bioinformatics, by Solution, Through 2025
Table 30 : Global Market for Bioinformatic Tools and Database Services, by Region, Through 2025
Table 31 : Bioinformatic Tools for Pharmacogenomic Software
Table 32 : Toxicogenomic Studies Planned or Ongoing, 2016
Table 33 : Bioinformatics Archival Databases
Table 34 : Bioinformatics Curative Databases
Table 35 : Commercially Available Bioinformatics Databases
Table 36 : Biological Databases for Human Research
Table 37 : Software for Biological Analysis
Table 38 : Open-Source Bioinformatics Software
Table 39 : NGS Platforms for Clinical Diagnostics
Table 40 : Commonly Used Tools for NGS-based DNA Analysis, by Functional Category
Table 41 : Commercially Available Integrated DNA Analysis Solutions and Relevant Functionality
Table 42 : Global Market for Data Analysis Software and Analytical Services, by Region, Through 2025
Table 43 : High-Performance Computing Architectures: Advantages and Drawbacks
Table 44 : Highest Performance Supercomputers, 2018
Table 45 : SaaS Products
Table 46 : Global Market for IT Hardware and Infrastructure, by Region, Through 2025
Table 47 : Global Market for Bioinformatics, by End User, Through 2025
Table 48 : Sequencing Data Analysis Bioinformatics Software and Tools
Table 49 : Global Market for Bioinformatics for Research End Users, by Region, Through 2025
Table 50 : Global Market for Bioinformatics for Clinical and Medical End Users, by Region, Through 2025
Table 51 : Bioinformatics-Based Clinical and Medical Laboratory Information Management System
Table 52 : Tools Used to Identify the Protein Structure in Bioinformatics for Healthcare Applications and Function
Table 53 : Number of Therapeutic Drugs Developed Globally, by Disease Type, 2017
Table 54 : Global Market for Other End Users of Bioinformatics, by Region, Through 2025
Table 55 : Global Market for Bioinformatics, by Region, Through 2025
Table 56 : Number of Grants, by Type of Cancer, 2017
Table 57 : North American Market for Bioinformatics, by Solution, Through 2025
Table 58 : North American Market for Sequencing Services and Platforms, Through 2025
Table 59 : North American Market for Bioinformatics, by Application, Through 2025
Table 60 : North American Market for Bioinformatics, by End User, Through 2025
Table 61 : North American Market for Bioinformatics, by Country, Through 2025
Table 62 : Leading Bioinformatics Companies in the U.S.
Table 63 : Venture Capital Companies Most Active in the Biotech Sector, 2015
Table 64 : Estimated New Male Cancer Cases in Canada, 2017
Table 65 : Estimated New Female Cancer Cases in Canada, 2017
Table 66 : Leading Canadian Bioinformatics Companies
Table 67 : European Market for Bioinformatics, by Solution, Through 2025
Table 68 : European Market for Sequencing Services and Platforms, Through 2025
Table 69 : European Market for Bioinformatics, by Application, Through 2025
Table 70 : European Market for Bioinformatics, by End User, Through 2025
Table 71 : European Market for Bioinformatics, by Country, Through 2025
Table 72 : Leading European Bioinformatics Companies
Table 73 : Deaths Caused by Cardiovascular Disease Compared with Other Causes of Death in Germany, 2016
Table 74 : Diseases Causing the Greatest Number of Premature Deaths in Germany, Percentage Change from 2005-2016
Table 75 : Asia-Pacific Market for Bioinformatics, by Solution, Through 2025
Table 76 : Asia-Pacific Market for Sequencing Services and Platforms, Through 2025
Table 77 : Asia-Pacific Market for Bioinformatics, by Application, Through 2025
Table 78 : Asia-Pacific Market for Bioinformatics, by End User, Through 2025
Table 79 : Asia-Pacific Market for Bioinformatics, by Country, Through 2025
Table 80 : Leading Indian Bioinformatics Companies
Table 81 : Incidence of All Cancers in Australia, by Sex, 2017
Table 82 : Rest of the World Market for Bioinformatics, by Solution, Through 2025
Table 83 : Rest of the World Market for Sequencing Services and Platforms, Through 2025
Table 84 : Rest of the World Market for Bioinformatics, by Application, Through 2025
Table 85 : Rest of the World Market for Bioinformatics, by End User, Through 2025
Table 86 : Rest of the World Market for Bioinformatics, by Country, Through 2025
Table 87 : Research and Development (R&D) Spending per Capita
Table 88 : Bioinformatics Databases
Table 89 : Leading Drug Target Databases
Table 90 : Computer Simulation Platforms
Table 91 : Application of Cloud-Based Services in Healthcare
Table 92 : Leading LIMS Providers
Table 93 : Key Suppliers of ELNs
Table 94 : Leading Absorption, Distribution, Metabolism, Excretion and Toxicity Prediction Tools
Table 95 : Drug R&D Process Overview
Table 96 : Leading EHR Providers, 2018
Table 97 : Medical Applications for Healthcare Professionals
Table 98 : Pharmaceutical and Bioinformatic Partnerships and Alliances, 2015-2020
Table 99 : Agilent Technologies Inc.: Product Portfolio
Table 100 : Biomatters Ltd.: Product Portfolio
Table 101 : Bio-Rad: Product Portfolio
Table 102 : Bio-Techne: Product Portfolio
Table 103 : Compugen Ltd.: Product Portfolio
Table 104 : Dassault Systemes Biovia: Product Portfolio
Table 105 : DNASTAR Inc.: Product Portfolio
Table 106 : DNASTAR Inc.: Recent Developments, 2016
Table 107 : Genedata AG: Product Portfolio
Table 108 : Genedata AG: Recent Developments, 2017
Table 109 : Geneva Bioformatics (GeneBio) SA: Product Portfolio
Table 110 : Genomatix Software GmbH: Product Portfolio
Table 111 : GNS Healthcare Inc.: Product Portfolio
Table 112 : GNS Healthcare Inc.: Recent Developments, 2017
Table 113 : GVK Biosciences Pvt. Ltd.: Product Portfolio
Table 114 : GVK Biosciences Pvt. Ltd: Recent Developments, 2020
Table 115 : Illumina Inc.: Product Portfolio
Table 116 : Illumina Inc.: Recent Developments, 2020
Table 117 : Inte:Ligand Software Entwicklungs Und Consulting GmbH: Product Portfolio
Table 118 : MacVector Inc.: Product Portfolio
Table 119 : Molecular Connections Pvt. Ltd.: Product Portfolio
Table 120 : Molecular Networks GmbH: Product Portfolio
Table 121 : Nonlinear Dynamics Ltd.: Product Portfolio
Table 122 : Ocimum Biosolutions Ltd.: Product Portfolio
Table 123 : PerkinElmer Informatics Inc.: Product Portfolio
Table 124 : Personalis Inc.: Product Portfolio
Table 125 : Qlucore AB: Product Portfolio
Table 126 : Qlucore AB: Recent Developments, 2018
Table 127 : Real Time Genomics Inc.: Product Portfolio
Table 128 : Real Time Genomics Inc.: Recent Developments, 2016
Table 129 : Smartgene Services SARL: Product Portfolio
Table 130 : Smartgene Services SARL: Recent Developments, 2020
Table 131 : Syngene International: Product Portfolio
Table 132 : Syngene International: Recent Developments, 2019
Table 133 : Thermo Fisher Scientific: Product Portfolio
Table 134 : Acronyms Used in This Report

Reason to Buy

  • Current and future of Others Market outlook in the developed and emerging markets
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The segment that is expected to dominate the Others Market
  • Regions that are expected to witness the fastest growth during the forecast period
  • Identify the latest developments, Others Market shares, and strategies employed by the major market players
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Others Market
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets